| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 177 | 2021 |
| Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study TR Tromp, ML Hartgers, GK Hovingh, AJ Vallejo-Vaz, KK Ray, H Soran, ... The Lancet 399 (10326), 719-728, 2022 | 89 | 2022 |
| HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients R Scicali, P Giral, A Gallo, A Di Pino, AM Rabuazzo, F Purrello, P Cluzel, ... Atherosclerosis 255, 102-108, 2016 | 83 | 2016 |
| Effects of age, blood pressure and antihypertensive treatments on retinal arterioles remodeling assessed by adaptive optics D Rosenbaum, A Mattina, E Koch, F Rossant, A Gallo, N Kachenoura, ... Journal of hypertension 34 (6), 1115-1122, 2016 | 74 | 2016 |
| High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjects R Scicali, P Giral, L d'Erasmo, P Cluzel, A Redheuil, A Di Pino, ... Diabetes/metabolism research and reviews 37 (2), e3367, 2021 | 59 | 2021 |
| The added value of coronary calcium score in predicting cardiovascular events in familial hypercholesterolemia A Gallo, L Perez de Isla, S Charrière, A Vimont, R Alonso, ... Cardiovascular imaging 14 (12), 2414-2424, 2021 | 52 | 2021 |
| The position of functional foods and supplements with a serum LDL-C lowering effect in the spectrum ranging from universal to care-related CVD risk management S Baumgartner, E Bruckert, A Gallo, J Plat Atherosclerosis 311, 116-123, 2020 | 51 | 2020 |
| Measuring the interaction between the macro-and micro-vasculature RE Climie, A Gallo, DS Picone, N Di Lascio, TT Van Sloten, A Guala, ... Frontiers in cardiovascular medicine 6, 169, 2019 | 46 | 2019 |
| Lipoprotein metabolism in familial hypercholesterolemia K Chemello, J García-Nafría, A Gallo, C Martín, G Lambert, D Blom Journal of Lipid Research 62, 2021 | 44 | 2021 |
| An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects R Scicali, D Rosenbaum, A Di Pino, P Giral, P Cluzel, A Redheuil, S Piro, ... Acta diabetologica 55, 741-749, 2018 | 39 | 2018 |
| Early coronary calcifications are related to cholesterol burden in heterozygous familial hypercholesterolemia A Gallo, P Giral, A Carrié, V Carreau, S Béliard, R Bittar, M Maranghi, ... Journal of clinical lipidology 11 (3), 704-711. e2, 2017 | 39 | 2017 |
| High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia: The French Familial Hypercholesterolemia Registry S Béliard, F Boccara, B Cariou, A Carrié, X Collet, M Farnier, J Ferrières, ... Atherosclerosis 277, 334-340, 2018 | 35 | 2018 |
| SAFEHEART risk-equation and cholesterol-year-score are powerful predictors of cardiovascular events in French patients with familial hypercholesterolemia A Gallo, S Charriere, A Vimont, MJ Chapman, D Angoulvant, F Boccara, ... Atherosclerosis 306, 41-49, 2020 | 33 | 2020 |
| Retinal arteriolar remodeling evaluated with adaptive optics camera: relationship with blood pressure levels A Gallo, A Mattina, D Rosenbaum, E Koch, M Paques, X Girerd Annales de Cardiologie et d'Angeiologie 65 (3), 203-207, 2016 | 30 | 2016 |
| ApoCIII: A multifaceted protein in cardiometabolic disease L d'Erasmo, A Di Costanzo, A Gallo, E Bruckert, M Arca Metabolism 113, 154395, 2020 | 26 | 2020 |
| Familial chylomicronemia syndrome (FCS): recent data on diagnosis and treatment A Gallo, S Béliard, L D’erasmo, E Bruckert Current Atherosclerosis Reports 22, 1-6, 2020 | 26 | 2020 |
| A novel splicing mutation in the ABCA1 gene, causing Tangier disease and familial HDL deficiency in a large family M Maranghi, G Truglio, A Gallo, E Grieco, A Verrienti, A Montali, P Gallo, ... Biochemical and biophysical research communications 508 (2), 487-493, 2019 | 24 | 2019 |
| Evaluation of efficacy and safety of antisense inhibition of apolipoprotein C-III with volanesorsen in patients with severe hypertriglyceridemia L D’erasmo, A Gallo, A Di Costanzo, E Bruckert, M Arca Expert Opinion on Pharmacotherapy 21 (14), 1675-1684, 2020 | 23 | 2020 |
| Polyvascular subclinical atherosclerosis in familial hypercholesterolemia: The role of cholesterol burden and gender A Mattina, A Giammanco, P Giral, D Rosenbaum, A Carrié, P Cluzel, ... Nutrition, Metabolism and Cardiovascular Diseases 29 (10), 1068-1076, 2019 | 23 | 2019 |
| Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey L D’erasmo, A Gallo, AB Cefalù, A Di Costanzo, S Saheb, A Giammanco, ... Orphanet Journal of Rare Diseases 16, 1-12, 2021 | 19 | 2021 |
Xavier GirerdProfesseur des UniversitésVerified email at aphp.fr
